申请人:Noronha Glenn
公开号:US20070161645A1
公开(公告)日:2007-07-12
A compound is provided, having the general structure (A):
wherein A is an aryl or heteroaryl group, Y is a hydrophbic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.
提供了一种化合物,具有一般结构(A):其中A是芳基或杂环芳基基团,Y是疏水连接基团,L是取代基。化合物(A)可用于治疗各种血管生成相关或血液学疾病,例如对于不对目前使用的药物进行激酶抑制治疗反应的患者的骨髓增生性疾病。